Announcements Trials

Browse Landscape

Phase

Phase NA 5 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Burkitt Lymphoma 8 Multiple Myeloma 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Biphenotypic, Acute 3 Down Syndrome 2 Vomiting 1 Smoldering Multiple Myeloma 1 Opsoclonus-Myoclonus Syndrome 1 Neuroblastoma 1 Nausea 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Leukemia 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Congenital Abnormalities 1 Breast Neoplasms 1

Interventions

Dexamethasone 23 Ondansetron 12 Palonosetron 11 Aprepitant 9 Granisetron 7 Olanzapine 5 ramosetron 3 netupitant, palosentron drug combination 3 casopitant 3 Radiotherapy 3 fosaprepitant 2 Thalidomide 2 Prochlorperazine 2 Electroacupuncture 2 Dronabinol 2 Analgesia 2 Acupressure 2 sinomenine 1 netupitant 1 lerisetron 1 dolasetron 1 dexamethasone acetate 1 Tropisetron 1 Therapeutics 1 Taxes 1 Tablets 1 Surveys and Questionnaires 1 Sugars 1 Metoclopramide 1 Hygiene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Vomiting × dexamethasone acetate × Clear all

NCT00003213 2012-07-11

Drugs to Reduce the Side Effects of Chemotherapy

Swiss Cancer Institute

Phase 3 Completed

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡